Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$1.2 million.

  • Tonix Pharmaceuticals Holding's Other Non Operating Income fell 252727.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 44126.21%. This contributed to the annual value of -$2.1 million for FY2024, which is 22073.17% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Other Non Operating Income stood at -$1.2 million for Q3 2025, which was down 252727.27% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Other Non Operating Income peaked at $172000.0 during Q3 2023, and registered a low of -$2.1 million during Q1 2025.
  • Moreover, its 3-year median value for Other Non Operating Income was -$606000.0 (2024), whereas its average is -$861555.6.
  • Data for Tonix Pharmaceuticals Holding's Other Non Operating Income shows a peak YoY increase of 12558.14% (in 2024) and a maximum YoY decrease of 2134285.71% (in 2024) over the last 5 years.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Other Non Operating Income (Quarter) stood at $7000.0 in 2023, then plummeted by 21342.86% to -$1.5 million in 2024, then increased by 22.26% to -$1.2 million in 2025.
  • Its Other Non Operating Income stands at -$1.2 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$2.1 million for Q1 2025.